Treatment Trials

MAPrc researchers regularly seek people who have experience with mental illness, as well as those who do not, for participation in research projects and treatment trials. See the drop-down menu above (under Treatment Trials) for details of current projects requiring research participants.

What is involved in participating will depend on the project, but it might involve one or more of the following:

Visiting MAPrc at the Alfred Hospital
Having a researcher visit at hospital or home
Completing questionnaires or participating in interviews by phone or face-to-face
Researchers speaking with doctors or case managers
Trying a new treatment, either instead of, or in addition to, current treatment. Treatments might be:
- Medication
- Hormone treatments
- Psychological therapies such as cognitive behavioural therapy (CBT).

Any personal information provided, and the record of participation, is treated as private health information and kept confidential.

All MAPrc studies have been approved, and are governed by, the Alfred Hospital Ethics Committee.

If you would like to forward a general expression of interest in participating in any of our research projects, please contact our centre on +61 (0)3 9076 6564 or email info.maprc@monash.edu

Complex Trauma Disorder (Borderline Personality Disorder)

Current treatment trials for Complex Trauma Disorder:

The Alison Project: understanding Complex Trauma Disorder and the role of Memantine

The Sarah Kelly Jones Scholarship in Complex Trauma Disorder:

In honour of Sarah Kelly Jones who lost her life to Complex Trauma Disorder earlier this year (2020), we are proud and privileged to establish the Sarah Kelly Jones Scholarship in complex trauma disorder to support a PhD candidate or medical doctor who will conduct focused research in this area to improve our understanding of this disorder and work to establish and promote new treatments for people living with CTD. With the support of the Jones family and many of Sarah's friends and supporters in Perth, W.A, an annual amount will be fund raised and donated to fund this scholarship. We look forward to awarding the scholarship in early 2021 once it has been established and to providing updates on the work conducted in this area.

Sarah Kelly Jones

Resources for Complex Trauma Disorder:

1. How To Treat: Borderline Personality Disorder (Australian Doctor). This article was originally published by Australian Doctor. To see other articles like this click here.

Depression

MAPrc’s researchers are currently working on a number of projects investigating new diagnostic and treatment methods for people experiencing depression

CLICK HERE TO FIND OUT MORE

The following projects are currently recruiting participants. Please contact us if you wish to receive information or take part in a project.

Mood and Oral Contraceptives

An observational study of women taking / not taking hormonal contraception (i.e. COCP, POP, Implanon, DMPA) exploring current mood & risk and resistance factors for adverse mood change. To take part in this study you must be a female 18 years of age or older, able to give informed consent and not currently pregnant, breast-feeding or menopausal. For further information click here or contact our friendly team on 9076 6564 or email info.maprc@monash.edu

Schizophrenia

MAPrc’s researchers are currently working on a number of projects investigating new treatment methods for people experiencing schizophrenia

The following projects are currently recruiting participants. Please contact us if you wish to receive futher information or take part in a project.

The Damian Project - The Use of Bazadoxifene as a Potential Treatment for Men with Schizophrenia

Thanks to the generous support of the Mohr family, and in honour of the memory of Damian Mohr, MAPrc is privileged to be able to conduct this exiciting new trial to explore the use of Bazadoxifene, a Selective Estrogen Receptor Modulator (SERM), as a potential treatment for men with Schizophrenia.

Adjunctive SERM Hormone Treatment for Men and Women with Schizophrenia and Schizoaffective Disorder

Men and women who are 18 and over, with schizophrenia or schizoaffective disorder, are invited to take part in a 12-week adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a medication that targets hormone receptors in the brain, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. For further details click here